Jane Street
TNGX icon

Jane Street’s Tango Therapeutics TNGX Stock Holding History

Jane Street’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-352,897
Closed -$483K – 10896
2025
Q1 		$483K Buy
352,897
+257,668
+271% +$633K ﹤0.01% 6925
2024
Q4 		$294K Buy
95,229
+44,465
+88% +$206K ﹤0.01% 7770
2024
Q3 		$391K Sell
50,764
-18,126
-26% -$173K ﹤0.01% 7603
2024
Q2 		$591K Buy
68,890
+16,262
+31% +$126K ﹤0.01% 6736
2024
Q1 		$418K Sell
52,628
-33,596
-39% -$360K ﹤0.01% 7006
2023
Q4 		$854K Buy
+86,224
New +$748K ﹤0.01% 5852
2023
Q3 		– Sell
-20,592
Closed -$68.4K – 9391
2023
Q2 		$68.4K Buy
20,592
+5,968
+41% +$21.5K ﹤0.01% 8139
2023
Q1 		$57.8K Buy
+14,624
New +$84.9K ﹤0.01% 8413
2022
Q2 		– Sell
-32,656
Closed -$248K – 10886
2022
Q1 		$248K Buy
+32,656
New +$283K ﹤0.01% 8697

Other funds holding TNGX

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

Jane Street's TNGX Position: Q2 2025 in Review

Jane Street sold out of Tango Therapeutics (TNGX) in Q2 2025, closing a stake of 352,897 shares — an estimated $483K sold.

Jane Street first reported a position in TNGX in Q1 2022 and held it in 9 quarters. The position peaked at $854K in Q4 2023. 115 funds tracked by Wall St. Rank hold TNGX as of Q2 2025.

  • Jane Street reported no remaining Tango Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Jane Street sold 352,897 Tango Therapeutics shares in Q2 2025, an estimated $483K.
  • Jane Street first reported a position in Tango Therapeutics in Q1 2022 and held it in 9 quarters.
  • Jane Street's Tango Therapeutics position peaked at $854K in Q4 2023.
  • 115 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2025.

Based on Jane Street's 13F filing for Q2 2025, filed 14 Aug 2025.